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OBJECTIVE: This study evaluated the performance of lungs that were preserved with different solutions (Celsior,
Perfadex or saline) in an ex vivo rat lung perfusion system.
METHODS: Sixty Wistar rats were anesthetized, anticoagulated and randomized into three groups (n= 20). The rats
were subjected to antegrade perfusion via the pulmonary artery with Perfadex, Celsior, or saline, followed by 6 or
12 hours of ischemia (4˚C, n = 10 in each group). Respiratory mechanics, gas exchange and hemodynamics were
measured at 10-minute intervals during the reperfusion of heart-lung blocks in an ex vivo system (IL2-Isolated
Perfused Rat or Guinea Pig Lung System, Harvard Apparatus, Holliston, Massachusetts, USA; Hugo Sachs Elektronik,
Germany) for 60 minutes. The lungs were prepared for histopathology and evaluated for edema following
reperfusion. Group comparisons were performed using ANOVA and the Kruskal-Wallis test with a 5% level of
significance.
RESULTS: Gas exchangewas not significantly different between lungs perfusedwith either Perfadex or Celsior at the same
ischemic times, but it was very low in lungs that were preservedwith saline. Airway resistancewas greater in the lungs that
were preserved for 12 hours. Celsior lungs that were preserved for 6 and 12 hours exhibited lower airway resistance
(p=0.01) compared to Perfadex lungs. Pulmonary artery pressurewas not different between the groups, andno significant
differences in histopathology and apoptosis were observed between the groups.
CONCLUSIONS: Lungs that were preserved with Celsior or Perfadex exhibited similar gas exchange and
histopathological findings. Airway resistance was slightly lower in the Celsior-preserved lungs compared with the
Perfadex-preserved lungs.
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INTRODUCTION
Lung transplantation is a well-established treatment for
end-stage lung disease. However, lung transplant-related
mortality remains significant despite the increasing number
of transplants that are performed (over 3,200 in 2010) (1).
Ischemia-reperfusion injury is the primary cause of lung
transplant-related mortality. The severity of injury depends
on several factors, including the quality of lung preserva-
tion, which is important in the early stages after transplan-
tation (2).
Lung preservation for transplantation enables distant
organ procurement, objectively improves organ quality after
reperfusion and decreases post-ischemic reperfusion injury.
The most widely used preservation method is hypothermia
with the administration of preservation solutions with or
without pulmonary vasodilators (3,4).
Low-potassium preservation solutions are classified as
extracellular-type solutions and include Perfadex and
Celsior, which are most commonly used for lung preserva-
tion. The Celsior solution was originally developed for
heart preservation (2), and Perfadex was developed for lung
preservation (5).
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Perfadex was gradually introduced after its original
development two decades ago, despite the superiority of
the experimental results obtained from this solution
compared with other solutions (2). The use of preservation
solutions in the lungs reduces the incidence of acute graft
failure after transplantation from 30% to less than 15% (2).
Controversy exists over the benefits of Perfadex based on its
late clinical performance and associated 1-year post-trans-
plant mortality rate (2). The recent introduction of ex vivo
lung reconditioning and donation after cardiocirculatory
arrest has rekindled this controversy and reinforced the
need for the reassessment of the currently used preservation
solutions (6).
Ex vivo lung perfusion systems are useful for experi-
mental physiological evaluations because of its reproduci-
bility and relatively low cost for assessments of lung
preservation methods (7,8).
This study compared the functional performance of rat
lungs that were subjected to different ischemic times;
preserved with Perfadex, Celsior or normal saline; and
reperfused in an ex vivo lung perfusion system.
MATERIALS AND METHODS
Animals were handled in accordance with the Guide for
the Care and Use of Laboratory Animals prepared by the
Institute of Laboratory Animal Research and published by
the National Academies Press, 8th Edition, 2011.
Male Wistar rats (250 to 300 g) were anesthetized with
sodium thiopental (50 mg/kg, intraperitoneally) and subjected
to sternolaparotomy, tracheostomy, and mechanical ventilation
(room air; tidal volume (Vt)=10 mL/kg body weight; respira-
tory rate (RR)=70 cycles/min; and positive end expiratory
pressure (PEEP)=1 cmH2O). The diaphragm was opened
radially to expose the supradiaphragmatic vena cava after
anticoagulation (heparin 1,500 IU via the inferior vena cava).
The right ventricle outflow tract was incised adjacent to the
pulmonary artery, the inferior vena cava and the left ventricle.
The pulmonary artery was cannulated through right ventricu-
lotomy, and the lungswere perfused antegradelywith 20 mL of
a hypothermic solution (4 C˚) at a pressure of 10 cmH2O, which
was obtained by the elevation of the reservoir. The effluent was
drained via the left ventriculotomy. Animals were randomized
into three groups (n=20 each) based on the perfused
preservation solution: PerfadexH (Vitrolife, Kungsbacka,
Sweden), CelsiorH (Genzyme, Catalent Limoges S.A.S.,
France) or a 0.9% saline solution (Baxter, Sa˜o Paulo, Brazil).
The heart-lung block was removed partially inflated at the end
of perfusion, immersed in the perfusion solution and stored at
4-7 C˚ for 6 or 12 hours according to group assignment. The
animals were divided into two groups (n=30) according to
ischemic time (6 or 12 hours), and each group was subdivided
into three groups (n=10) according to perfusion solution.
The heart-lung block was connected to the ex vivo
perfusion system at the end of the cold ischemia period
(IL-2 Isolated Perfused Rat or Guinea Pig Lung System;
Harvard Apparatus, Holliston, MA, USA; Hugo Sachs
Elektronic, Hugstetten, Germany) and reperfused for 60
minutes using homologous blood from donor rats diluted in
saline to a hematocrit of 15-20%. The pulmonary venous
blood was deoxygenated using a membrane oxygenator (D-
150 Hemofilter, Medsulfone, Italy) that contained a con-
tinuously administered (100 mL/min flow rate) gas mixture
(90% N2 and 10% CO2).
Ventilation was initiated with the heart-lung block posi-
tioned in the ex vivo perfusion system (RR=60 bpm;
inspiratory/expiratory ratio = 60%; one breath/minute= 50%
increase in tidal volume; and PEEP= 1 cmH2O), beginning at
50% of the tidal volume and increasing until a ventilation of
10 mL/kg body weight was reached. Perfusion of the block
began at a low flow rate (2 mL/min) and was increased over
5-10 minutes until the desired flow rate (5-7 mL/min) was
reached. Ventilation and perfusion were stabilized, and data
(hemodynamics, ventilatory mechanics, and pulmonary
arterial and venous gases) were collected every 10 minutes
for 60 minutes.
Blood samples were taken from the pulmonary arterial
and left atrial cannulae for blood gas measurements (ABL
800, Radiometer, Denmark). The lung’s relative oxygenation
capacity (ROC) was calculated using the following formula:
ROC= [(PvO2-PaO2)6100]/PaO2 (7). The PaO2 corresponds
to the deoxygenated blood that was taken from the
pulmonary arterial cannula, and the PvO2 is the oxygenated
blood from the left atrial cannula. The pH of the blood in the
reservoir was corrected with sodium bicarbonate (0.3 mEq/
L/dose) to maintain the pH between 7.1-7.4 (9,10). The
ventilatory mechanics parameters were provided by the IL2
system and included tidal volume, lung compliance and
maximum inspiratory and expiratory flows. The hemody-
namic parameters included pulmonary artery pressure and
pulmonary resistance.
The left lung was dissected out at the end of perfusion.
The lung was weighed, stored at 70 C˚ for 72 hours, and re-
weighed for the calculation of the wet-to-dry (W/D) weight
ratio.
The right lung was immersed in 10% buffered neutral
formalin solution for 24 hours and then longitudinally
sectioned. The most volumetrically significant half was
selected for embedding and processing. The specimen
was dehydrated, diaphanized and embedded in paraffin.
Histological sections (5 mm thickness) were stained with
hematoxylin and eosin (HE) for light microscopy analysis.
Histopathological analyses of the fragments was performed
to assess the presence or absence of congestion, alveolar
edema, bleeding (alveolar and/or interstitial), acute throm-
bosis, interstitial inflammatory infiltrates (mononuclear
and/or granulocytic) and pneumonic foci.
Fragments were obtained from the right lung immedi-
ately after reperfusion for the detection and quantification of
apoptotic cells using the In situ Cell Death Detection
Kit (Roche, Mannheim, Germany). The fragments were
immersed in 10% buffered formalin for fixation for
24 hours. Paraffin blocks of the specimens were prepared
and sectioned into slices of 5 mm thick sections. The sections
were deparaffinized in three xylene baths (five minutes
each) and rehydrated in an ethanol gradient (100, 95, 90, 80,
and 70%). Proteinase K was applied to the sections for 30
minutes at room temperature. The sections were washed in
two (three minutes each) PBS (phosphate-buffered saline)
baths. The sections were incubated in a 0.3% hydrogen
peroxide (H2O2) and methanol solution for 30 minutes at
room temperature and immediately washed twice in PBS. A
TUNEL mixture (50 ml:5 ml of the TdT enzyme solution and
45 ml of the labeled nucleotide solution) was applied to each
specimen. The specimens remained in the wet chamber at
37 C˚ for 60 minutes. The sections were washed three times
in PBS and coverslipped with glycerin for fluorescence
microscopy analysis.
Lung preservation: Celsior vs. Perfadex
Menezes AQ et al.
CLINICS 2012;67(11):1309-1314
1310
Small fragments of the right lung (approximately 2 mm
62 mm) were used for transmission electron microscopy
analysis. The material was placed in universal fixative (1%
glutaraldehyde, 1% paraformaldehyde, pH=7.4) immedi-
ately after biopsy, postfixed in osmium tetroxide (2%),
dehydrated, and embedded in epon-araldite. Slices (1 mm
thick) were analyzed using a transmission electron micro-
scope for the qualitative evaluation of apoptotic changes in
type II pneumocytes.
Statistical analysis
Statistical analyses included the parametric ANOVA and
nonparametric Kruskal-Wallis tests. The chi-square test was
employed for qualitative variables. The data are presented
as the means and standard errors of the mean, and the
significance level in this study was 5% (p,0.05). Descriptive
and inferential statistical analyses were performed with
SPSS software version 13 (SPSS 13.0 for Windows).
RESULTS
The ROC of Celsior lungs was superior to that of Perfadex
or saline lungs, regardless of the ischemic time. However,
this difference did not reach statistical significance (6 hours,
p= 0.75; 12 hours, p= 0.18). Oxygenation was lowest in the
lungs that were preserved with saline for 12 hours
(p= 0.001). However, no significant differences between
Celsior and Perfadex lungs were observed at either ischemic
time (Perfadex, p= 0.06; Celsior, p= 0.17) (Figure 1).
The compliance of the lungs that were preserved with
Celsior was superior to that of the saline lungs at 6 hours
(p= 0.03) but not at 12 hours (p= 0.07). However, lung
compliance was not different between the Celsior and
Perfadex lungs at either ischemic time (6 hours, p= 0.16;
12 hours, p= 0.31). Overall, the compliance of the 6-hour
lungs was greater than that of the 12-hour lungs (Perfadex,
p= 0.02; Celsior, p = 0.01; saline, p= 0.01) (Figure 2).
The Celsior lungs exhibited the lowest airway resistance
for both ischemic times (p = 0.01). The Perfadex-preserved
lungs exhibited lower pulmonary resistance than the saline-
preserved lungs at 6 hours (p = 0.03), but this difference was
not observed at 12 hours (p= 0.16). Airway resistance was
higher in the 12-hour ischemic lungs regardless of the
preservation solution (Perfadex, p = 0.001; Celsior, p= 0.003;
saline, p= 0.006) (Figure 3).
Figure 1 - Mean relative oxygenation capacity (ROC) of rat lungs subjected to ischemia and reperfusion for 60 minutes, illustrating no
significant differences between Celsior- and Perfadex-perfused lungs at either ischemic time. The lungs subjected to 6 hours of cold
ischemia exhibited higher ROCs than the 12-hour ischemic lungs, but this difference was significant only for the lungs preserved with
saline (p=0.001).
Figure 2 - Mean lung compliance of rat lungs submitted to ischemia and reperfusion for 60 minutes, illustrating no significant differences
between lungs preserved with Celsior and Perfadex. Lungs subjected to ischemia for 6 hours performed better than those subjected to
12 hours of ischemia.
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TheW/D ratio was not different between the 6- and 12-hour
lungs regardless of the preservation solution (p= 0.29 and
p= 0.26, respectively). The Perfadex-preserved lungs exhibited
a higher W/D ratio at 12 hours of ischemia compared with
6 hours (Perfadex, p= 0.001; Celsior, p=0.27; saline, p=0.13).
Pulmonary artery pressure was not different between the 6-
and 12-hour lungs regardless of the preservation solution
(p= 0.88 and p= 0.98, respectively), and no significant differ-
ence between lungs in the two ischemic time groups was
observed (Perfadex, p= 0.17; Celsior, p= 0.34; saline, p= 0.19).
The saline-preserved lungs exhibited the highest levels of
alveolar edema on light microscopy regardless of the
ischemic time (6 hours, p= 0.006; 12 hours, p = 0.001). The
Celsior and Perfadex lungs exhibited some level of alveolar
edema at both ischemic times (6 hours, p= 0.131; 12 hours,
p = 1.00), but no significant differences in edema formation
across groups and between 6- and 12-hour ischemic lungs
were observed (Perfadex, p = 0.37; Celsior, p= 0.3; saline,
p = 0.47) (Figure 4).
No differences in type II pneumocyte changes were
observed on electronmicroscopy between the different groups
and between the 6- and 12-hour ischemic lungs. Very few
epithelial cells exhibited gross chromatin aggregates periph-
eral to the nucleus, which is indicative of the initial stages of
apoptosis. A slight thickening of the basement membrane due
to edema was observed in all groups (Figure 5).
The TUNEL assay for the assessment of apoptosis did not
demonstrate any statistically significant differences between
groups, regardless of the preservation solution and ischemic
time (Figure 6).
DISCUSSION
This study demonstrated a similar reperfusion perfor-
mance of gas exchange in lungs that were preserved with
Perfadex or Celsior. Both Perfadex and Celsior are extra-
cellular solutions, but the potassium content of the Perfadex
solution is lower than that of the Celsior solution (4 vs.
15 mEq/L, respectively). Therefore, Perfadex is potentially
less harmful to the structural and functional integrity of
endothelial cells and may, as a result, decrease the pro-
duction of oxidants and vasoconstrictors. The addition of
Dextran-40 increases the oncotic pressure, which improves
the deforming capacity of red blood cells, prevents erythro-
cyte aggregation and induces disaggregation of the aggre-
gated red blood cells. Therefore, Dextran-40 elicits an
Figure 3 - Airway resistance of rat lungs subjected to ischemia and reperfusion for 60 minutes. The Celsior lungs exhibited the lowest
airway resistance for both ischemic times. The airway resistance was lower in lungs submitted to 6 hours of ischemia compared with
those submitted to 12 hours of ischemia.
Figure 4 - Histopathology of lungs preserved for 6 hours with
Perfadex. Sites of mild alveolar edema can be observed (white
asterisks). Similar findings were observed in Celsior-preserved
lungs (hematoxylin-eosin, 200X magnification).
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antithrombotic effect due to its action on the surfaces of
endothelial cells and platelets. These effects improve lung
microcirculation and preserve the endothelial-epithelial
interface, which can reduce water and protein extravasation
during reperfusion (2).
Previous studies on the use of Celsior or Perfadex for lung
preservation reported comparable results, but these studies
used shorter ischemic times (7). The Celsior solution
contains antioxidant substances, such as histidine, mannitol,
lactobionate, and glutathione (11).
All lungs that were subjected to 6 or 12 hours of ischemia
in the present study completed the 60-minute reperfusion
period and provided consistent data for analysis. Other
authors have used ischemic times of 2 and 4 hours using the
same model used in the present study (7,12).
The ex vivo lung perfusion model is suitable for initial
evaluations of lung preservation because of its simplicity,
reproducibility, reliability, and low cost compared with
larger animal models (13).
Similar lung compliance results were found in this study
between the Celsior and Perfadex groups for both ischemic
times. The Celsior solution exhibited a tendency for
improved lung compliance during reperfusion, but this
difference was not significant. Sommer et al. observed
comparable lung compliances in a pig model in both
experimental groups after 24 hours of cold ischemia and
7 hours of reperfusion (14). Wittwer et al. also described
that dynamic lung compliance in a pig model remained
stable over 6 hours of reperfusion even after 27 hours of
hypothermic ischemia. These authors did not demonstrate a
significant difference between solutions regardless of the
perfusion route (antegrade or retrograde). However, pre-
servation with Celsior produced the lowest lung compliance
values across the investigated groups (15). Both preserva-
tion solutions in our study were associated with signifi-
cantly lower values of lung compliance after 12 hours of
ischemia, which suggested that this parameter was nega-
tively affected by longer ischemic times regardless of the
preservation solution.
Celsior performed better than Perfadex with regard to
airway resistance, as demonstrated by the lower resistances
measured during the reperfusion of the Celsior lungs.
Increased resistance may be secondary to the increases in
permeability and alveolar-capillary injury that result from
edema. However, airway resistance may vary due to the
denervation of the heart-lung block and to the airway
reactivity, which is less likely to play a role in this model.
However, the microscopic observations of alveolar edema
were similar in the Perfadex and Celsior lungs despite the
significant differences in airway resistance caused by these
two solutions.
Our experimental design included a saline solution group
to assess the stability and reliability of the model. The
absence of significant differences in oxygenation and
pulmonary resistance parameters between Perfadex and
saline lungs may be partly attributed to blood dilution.
Puskas et al described these effects in a similar ex vivo
perfusion model in which blood dilution with a crystalloid
solution significantly improved post-ischemic reperfusion
injury (2). The blood dilution may have been higher in the
saline group in the present model because the vascular bed
of the lungs was filled with saline prior to reperfusion. This
act may explain the lower pulmonary resistance values in
the saline-preserved lungs compared with the Perfadex
lungs for the 12-hour ischemic period. This act may also
underlie the biases that are inherent in the absence of the
body of the animal and its replacement with a deoxygena-
tor. The use of Krebs solution instead of saline may be an
option for preventing the aforementioned effects of blood
dilution.
Wittwer et al. (12) also observed no significant differences
in pulmonary artery pressure between Perfadex- and
Celsior-preserved lungs using a similar model. One limita-
tion of this model is that it does not enable the calculation of
pulmonary vascular resistance, which yields a better
assessment of pulmonary hemodynamics. These authors
used a swine model and pulmonary vascular resistance
calculations to conclude that preservation with Celsior
produced the highest resistance values, but Sommer et al.
(14) reported that Perfadex was inferior to Celsior.
The ROC is the parameter of choice for the assessment of
gas exchange in this ex vivo model and likely represents the
most important physiological parameter (7). We did not
Figure 5 - Pneumocyte with a tendency for peripheral chromatin
aggregation that is compatible with ongoing apoptosis (red
arrows) (transmission electron microscopy, 8900X magnification).
Figure 6 - Immunofluorescence microscopy (TUNEL) imaging for
cell death analysis. Fluorescent-labeled cells (green) correspond
to tissue death by apoptosis.
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observe a significant difference in the gas exchange perfor-
mance of Celsior lungs compared with Perfadex lungs at either
ischemic timepoint examined. A previous study using a similar
model with 4 hours of ischemia demonstrated differences
between the two solutions that favored Celsior (7), but the
ischemic time in the present study is three times longer.
However, the saline solution group exhibited a decline in ROC
for the longest ischemic time.
The W/D ratios demonstrated that the increased edema
during reperfusion was closely related to the ischemic time.
Increased edema results from post-ischemic reperfusion
injury and the characteristics of the ex vivo model, which
uses an extracorporeal circuit, inorganic interfaces and non-
pulsatile flow. The Perfadex-preserved lungs in the 6-hour
ischemic group exhibited a trend toward a lower weight
gain than the Celsior-preserved lungs, but this difference
was not statistically significant. The Perfadex solution is
associated with less edema regardless of the perfusion route
(15). An assessment of lung edema in pigs demonstrated
that Perfadex better prevents the formation of intra-alveolar,
peribronchovascular and septal edema and injury to the
alveolar-capillary barrier during ischemia-reperfusion than
Celsior (16). Another study demonstrated that the water
content of Perfadex lungs was not different than that of
Celsior lungs after 24 hours of cold ischemia and 7 hours of
reperfusion in pig lungs (14). Conversely, our study
demonstrated that Celsior lungs subjected to 12 hours of
ischemia were less edematous at the end of reperfusion than
Perfadex lungs. Overall lung performance in the Celsior
lungs that were subjected to 12 hours of ischemia was
similar to the 6-hour ischemic lungs, thus suggesting that
the use of the Celsior solution produced less edema than the
Perfadex solution over longer ischemic times. Unfortunately,
such differences did not achieve statistical significance, and
the results should be confirmed in future studies.
In conclusion, this animal model of ex vivo lung perfusion
demonstrated that lungs preserved with Perfadex and
Celsior exhibited similar gas exchange, hemodynamics
and histopathological findings. The Perfadex-preserved
lungs subjected to 12 hours of ischemia were more
edematous, but Celsior-preserved lungs exhibited slightly
better ventilatory mechanics, as suggested by the lower
airway resistance. Future studies are required to confirm
these results and clarify the underlying mechanisms.
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